Bristol-Myers Squibb Company
CARBOHYDRATE CONTENT OF CTLA4 MOLECULES

Last updated:

Abstract:

The invention provides for mammalian cells capable of producing recombinant CTLA4-Ig and variants thereof. The invention also provides for compositions comprising CTLA4-Ig and formulations thereof The invention further provides for methods for mass-producing CTLA4-Ig from mammalian cells capable of producing this recombinant protein, and for purifying the CTLA4-Ig.

Status:
Application
Type:

Utility

Filling date:

24 Jul 2018

Issue date:

16 Jan 2020